Earnings call transcript: Xaar sees 12% revenue growth in H2 2025

Revenue rose 12% YoY to GBP 60.1m with adjusted profit before tax of GBP 0.8m, beating consensus by 8%; Printhead division led with +22% revenue and gross margin improvement of 300bps to 40%. Operating expenditure increased 11% to support growth, net cash was GBP 4.9m (down YoY), and EPS division revenue declined, though management expects a turnaround in 2026. Market reaction was positive (stock +1.97% post-release), but risks include higher OpEx, EPS division weakness and geopolitical/macro uncertainty that could delay capital equipment purchases.

Analysis

Winners are not limited to the printhead vendor itself: OEM partners that quickly integrate turnkey Printbar solutions and specialty materials suppliers (high‑viscosity polymers, low‑melting wax chemistries) will capture outsized incremental margin as time‑to‑market shortens. Chinese OEMs and regional manufacturing hubs that reduce integration friction will accelerate adoption and compress the effective sales cycle, creating a feed‑forward loop that benefits nimble component suppliers but pressures legacy system integrators who rely on long development timelines.

Second‑order supply chain effects are meaningful and asymmetric. As Xaar de‑risks fluid formulations and ink delivery subsystems, demand for low‑volume, high‑margin consumables will rise first, favoring specialty chemical players and contract manufacturers able to scale quickly; conversely, incumbents with heavy fixed assets in legacy digital lines will see utilization risk and second‑hand market saturation slow their replacement cycles for years.

Key risks and catalysts sit on different horizons: in the near term (days–months) watch working capital, inventory turns and any incremental guidance cuts — these can flip sentiment fast; in the medium term (6–24 months) commercialization milestones from halo accounts and the success of higher‑temperature wax printhead projects are binary drivers of valuation; over multiple years the optionality of cross‑industry adoption (EV battery, PCB conformal coating, industrial casting) determines whether revenue retains high operating leverage or reverts to a lumpy pattern.

The market appears to be pricing discretionary execution rather than proven recurring revenue: operational gearing offers substantial upside if conversion rates improve modestly, but the same gearing amplifies downside if attrition remains high. That asymmetry argues for concentrated exposure with explicit downside protection rather than naked long positions that assume smooth, simultaneous commercialization across many verticals.

Key Decisions for Investors

• Long Xaar plc (XAR.L) equity on a 6–12 month horizon: enter on weakness/pullback >10% from recent highs, target +40–60% if two additional halo OEMs hit commercial shipments within 12 months; hard stop at -25% if cash conversion deteriorates or inventory turns stall. (R/R: ~2:1 to 3:1 assuming milestone delivery.)
• Buy a protective call spread on XAR.L to capture upside while limiting premium outlay: buy 12–18 month call at ~1.3x current spot and sell a higher 24 month call at ~1.9x spot to finance — max loss limited to net premium, upside paid if medium‑term commercialization accelerates. (R/R: asymmetric, limited downside.)
• Pair trade: long XAR.L / short incumbent printer OEM (eg. 6724.T Epson) — equal notional for 12–24 months to express a bet on faster adoption of high‑viscosity capable heads versus slow‑moving, scale incumbents. Reduce position if evidence shows incumbents accelerating compatible product launches or if Xaar’s installed base growth stalls. (R/R: directional hedge; aim for 30–50% gross return if tech adoption diverges.)
• Event short trigger: open a small short position in XAR.L (or buy puts) on any next‑quarter guidance that implies a rollback of commercialization timelines or a reacceleration of inventory build — exit if management reconfirms multiple customer shipments. (R/R: short‑term hedge against execution risk; tight stops required.)